These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 163223)
21. The feline oncornavirus-associated cell membrane antigen (FOCMA) is related to, but distinguishable from, FeLV-C gp70. Snyder HW; Singhal MC; Zuckerman EE; Jones FR; Hardy WD Virology; 1983 Dec; 131(2):315-27. PubMed ID: 6318434 [TBL] [Abstract][Full Text] [Related]
22. Remission of FeLV-associated lymphosarcoma and persistent viral infection after extracorporeal immunoadsorption of plasma using staphylococcal protein A columns: details of immune response. Snyder HW; Reed DE; Jones FR Semin Hematol; 1989 Apr; 26(2 Suppl 1):25-30. PubMed ID: 2543084 [TBL] [Abstract][Full Text] [Related]
23. Feline oncornavirus-associated cell membrane antigen: a viral and not a cellularly coded transformation-specific antigen of cat lymphomas. Vedbrat SS; Rasheed S; Lutz H; Gonda MA; Ruscetti S; Gardner MB; Prensky W Virology; 1983 Jan; 124(2):445-61. PubMed ID: 6186079 [TBL] [Abstract][Full Text] [Related]
24. Horizontal transmission of feline leukemia virus under natural conditions in a feline leukemia cluster household. Essex M; Cotter SM; Sliski AH; Hardy WD; Stephenson JR; Aaronson SA; Jarrett O Int J Cancer; 1977 Jan; 19(1):90-6. PubMed ID: 188773 [TBL] [Abstract][Full Text] [Related]
25. Feline oncovirus-associated cell membrane antigen and feline leukemia virus group-specific antigen expression in bone marrow and serum. Rice JB; Olsen RG J Natl Cancer Inst; 1981 Apr; 66(4):737-43. PubMed ID: 6262553 [TBL] [Abstract][Full Text] [Related]
26. Feline leukaemia virus and its clinical effects in cats. Mackey L Vet Rec; 1975 Jan; 96(1):5-11. PubMed ID: 163515 [TBL] [Abstract][Full Text] [Related]
27. Frequency and significance of feline leukemia virus infection in necropsied cats. Reinacher M; Theilen G Am J Vet Res; 1987 Jun; 48(6):939-45. PubMed ID: 3037951 [TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical identification of B and T lymphocytes in formalin-fixed, paraffin-embedded feline lymphosarcomas: relation to feline leukemia virus status, tumor site, and patient age. Jackson ML; Wood SL; Misra V; Haines DM Can J Vet Res; 1996 Jul; 60(3):199-204. PubMed ID: 8809383 [TBL] [Abstract][Full Text] [Related]
29. Feline oncornavirus-associated cell membrane antigen. II. Antibody titers in healthy cats from household and laboratory colony environments. Essex M; Cotter SM; Carpenter JL; Hardy WD; Hess P; Jarrett W; Schaller J; Yohn DS J Natl Cancer Inst; 1975 Mar; 54(3):631-5. PubMed ID: 164562 [TBL] [Abstract][Full Text] [Related]
30. Clearance of feline leukemia virus from persistently infected pet cats treated by extracorporeal immunoadsorption is correlated with an enhanced antibody response to FeLV gp 70. Snyder HW; Singhal MC; Hardy WD; Jones FR J Immunol; 1984 Mar; 132(3):1538-43. PubMed ID: 6319496 [TBL] [Abstract][Full Text] [Related]
31. [Feline leukemia virus (FeLV) and FeLV-associated diseases in cats: a review]. Weijer K; UytdeHaag F; Osterhaus AD Tijdschr Diergeneeskd; 1987 Jun; 112(12):726-37. PubMed ID: 3039686 [TBL] [Abstract][Full Text] [Related]
32. Effect of diethylcarbamazine on serum antibody to feline oncornavirus-associated cell membrane antigen in feline leukemia virus cats. Kitchen LW; Cotter SM J Clin Lab Immunol; 1988 Feb; 25(2):101-3. PubMed ID: 2836593 [TBL] [Abstract][Full Text] [Related]
33. Feline oncornavirus-associated cell membrane antigen. VI. Cytotoxic antibody in cats exposed to feline leukemia virus. Mathes LE; Yohn DS; Hoover EA; Essex M; Schaller JP; Olsen RG J Natl Cancer Inst; 1976 Jun; 56(6):1197-200. PubMed ID: 186623 [TBL] [Abstract][Full Text] [Related]
34. Hypocomplementemia associated with naturally occurring lymphosarcoma in pet cats. Kobilinsky L; Hardy WD; Day NK J Immunol; 1979 Jun; 122(6):2139-42. PubMed ID: 221581 [TBL] [Abstract][Full Text] [Related]
35. Incidence of localized feline leukemia virus infection in cats. Hayes KA; Rojko JL; Mathes LE Am J Vet Res; 1992 Apr; 53(4):604-7. PubMed ID: 1316726 [TBL] [Abstract][Full Text] [Related]
36. Leukemia specific antigens: FOCMA and immune surveillance. Essex M; Grant CK; Cotter SM; Sliski AH; Hardy WD Haematol Blood Transfus; 1979; 23():453-86. PubMed ID: 232469 [TBL] [Abstract][Full Text] [Related]
37. Feline leukemia virus infection: age-related variation in response of cats to experimental infection. Hoover EA; Olsen RG; Hardy WD; Schaller JP; Mathes LE J Natl Cancer Inst; 1976 Aug; 57(2):365-9. PubMed ID: 187771 [TBL] [Abstract][Full Text] [Related]
38. [Control of lymphosarcoma or leukaemia in cats and of feline leukaemia virus (author's transl)]. Weijer K; Daams JH Tijdschr Diergeneeskd; 1978 Sep; 103(18):943-7. PubMed ID: 211674 [TBL] [Abstract][Full Text] [Related]
39. Anemia associated with feline leukemia virus infection in cats. Mackey L; Jarrett W; Jarrett O; Laird H J Natl Cancer Inst; 1975 Jan; 54(1):209-17. PubMed ID: 163317 [TBL] [Abstract][Full Text] [Related]
40. Immunosuppressive properties of a virion polypeptide, a 15,000-dalton protein, from feline leukemia virus. Mathes LE; Olsen RG; Hebebrand LC; Hoover EA; Schaller JP; Adams PW; Nichols WS Cancer Res; 1979 Mar; 39(3):950-5. PubMed ID: 218725 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]